KR102449136B1 - Compositions containing Taraxacum coreanum extract - Google Patents
Compositions containing Taraxacum coreanum extract Download PDFInfo
- Publication number
- KR102449136B1 KR102449136B1 KR1020200086596A KR20200086596A KR102449136B1 KR 102449136 B1 KR102449136 B1 KR 102449136B1 KR 1020200086596 A KR1020200086596 A KR 1020200086596A KR 20200086596 A KR20200086596 A KR 20200086596A KR 102449136 B1 KR102449136 B1 KR 102449136B1
- Authority
- KR
- South Korea
- Prior art keywords
- white dandelion
- extract
- dandelion flower
- white
- cosmetic composition
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 48
- 239000000203 mixture Substances 0.000 title claims abstract description 42
- 241001272081 Taraxacum coreanum Species 0.000 title description 2
- 241000245665 Taraxacum Species 0.000 claims abstract description 61
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 61
- 239000002537 cosmetic Substances 0.000 claims abstract description 36
- 239000004480 active ingredient Substances 0.000 claims abstract description 22
- 230000002087 whitening effect Effects 0.000 claims abstract description 14
- 230000037303 wrinkles Effects 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 33
- 230000036541 health Effects 0.000 claims description 17
- 235000013376 functional food Nutrition 0.000 claims description 15
- 230000006872 improvement Effects 0.000 claims description 4
- 241000186679 Lactobacillus buchneri Species 0.000 claims description 3
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 3
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 3
- 241000186612 Lactobacillus sakei Species 0.000 claims description 3
- 241000192130 Leuconostoc mesenteroides Species 0.000 claims description 3
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 3
- 230000003078 antioxidant effect Effects 0.000 abstract description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 40
- 239000000047 product Substances 0.000 description 31
- 230000000052 comparative effect Effects 0.000 description 18
- 238000002360 preparation method Methods 0.000 description 16
- 230000000694 effects Effects 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 230000005764 inhibitory process Effects 0.000 description 12
- 102000003425 Tyrosinase Human genes 0.000 description 11
- 108060008724 Tyrosinase Proteins 0.000 description 11
- 239000006210 lotion Substances 0.000 description 11
- 102000029816 Collagenase Human genes 0.000 description 10
- 108060005980 Collagenase Proteins 0.000 description 10
- 239000012153 distilled water Substances 0.000 description 10
- 229930003935 flavonoid Natural products 0.000 description 10
- 150000002215 flavonoids Chemical class 0.000 description 10
- 235000017173 flavonoids Nutrition 0.000 description 10
- 239000004615 ingredient Substances 0.000 description 10
- 235000013824 polyphenols Nutrition 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 229960002424 collagenase Drugs 0.000 description 9
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- 239000006071 cream Substances 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 150000008442 polyphenolic compounds Chemical class 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 239000003205 fragrance Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- -1 polyphenol compounds Chemical class 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000003086 colorant Substances 0.000 description 6
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 230000002000 scavenging effect Effects 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 239000000469 ethanolic extract Substances 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 230000002292 Radical scavenging effect Effects 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 229960000458 allantoin Drugs 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 3
- SNPLKNRPJHDVJA-UHFFFAOYSA-N dl-panthenol Chemical compound OCC(C)(C)C(O)C(=O)NCCCO SNPLKNRPJHDVJA-UHFFFAOYSA-N 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 229940074391 gallic acid Drugs 0.000 description 3
- 235000004515 gallic acid Nutrition 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 229920002535 Polyethylene Glycol 1500 Polymers 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- 229940079894 benzophenone-9 Drugs 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- QDCHWIWENYCPIL-UHFFFAOYSA-L disodium;4-hydroxy-5-(2-hydroxy-4-methoxy-5-sulfonatobenzoyl)-2-methoxybenzenesulfonate Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC(S([O-])(=O)=O)=C(OC)C=C1O QDCHWIWENYCPIL-UHFFFAOYSA-L 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000020510 functional beverage Nutrition 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000401 methanolic extract Substances 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 2
- 229940113124 polysorbate 60 Drugs 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- VUYXVWGKCKTUMF-UHFFFAOYSA-N tetratriacontaethylene glycol monomethyl ether Chemical compound COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO VUYXVWGKCKTUMF-UHFFFAOYSA-N 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- WLJYNHBZKOQNNI-UHFFFAOYSA-N 5-(diaminomethylideneamino)-2-[[1-[2-[[4-methyl-2-[[1-[(4-phenyldiazenylphenyl)methoxycarbonyl]pyrrolidine-2-carbonyl]amino]pentanoyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]pentanoic acid Chemical compound C1CCC(C(=O)NC(CCCN=C(N)N)C(O)=O)N1C(=O)CNC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)OCC(C=C1)=CC=C1N=NC1=CC=CC=C1 WLJYNHBZKOQNNI-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- YDDGKXBLOXEEMN-IABMMNSOSA-L Chicoric acid Natural products C1=C(O)C(O)=CC=C1\C=C\C(=O)O[C@@H](C([O-])=O)[C@H](C([O-])=O)OC(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-IABMMNSOSA-L 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- YDDGKXBLOXEEMN-UHFFFAOYSA-N Di-E-caffeoyl-meso-tartaric acid Natural products C=1C=C(O)C(O)=CC=1C=CC(=O)OC(C(O)=O)C(C(=O)O)OC(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 102000006995 beta-Glucosidase Human genes 0.000 description 1
- 108010047754 beta-Glucosidase Proteins 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- YDDGKXBLOXEEMN-IABMMNSOSA-N chicoric acid Chemical compound O([C@@H](C(=O)O)[C@@H](OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-IABMMNSOSA-N 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229930016920 cichoric acid Natural products 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- YDDGKXBLOXEEMN-PMACEKPBSA-N dicaffeoyl-D-tartaric acid Natural products O([C@H](C(=O)O)[C@H](OC(=O)C=CC=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-PMACEKPBSA-N 0.000 description 1
- YDDGKXBLOXEEMN-WOJBJXKFSA-N dicaffeoyl-L-tartaric acid Natural products O([C@@H](C(=O)O)[C@@H](OC(=O)C=CC=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-WOJBJXKFSA-N 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000010200 folin Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000012035 limiting reagent Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000019488 nut oil Nutrition 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- CKQVRZJOMJRTOY-UHFFFAOYSA-N octadecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O CKQVRZJOMJRTOY-UHFFFAOYSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000012860 organic pigment Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 description 1
- 229960004245 silymarin Drugs 0.000 description 1
- 235000017700 silymarin Nutrition 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000010421 standard material Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/82—Preparation or application process involves sonication or ultrasonication
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Botany (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Microbiology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
본 발명은 흰민들레 꽃 추출물을 유효성분으로 함유하는 화장료 조성물에 관한 것으로, 흰민들레 꽃을 유효성분으로 포함함으로써, 항산화 효과가 우수하며, 피부 미백 및 피부 주름완화에 효과가 있다.The present invention relates to a cosmetic composition containing a white dandelion flower extract as an active ingredient, and by including white dandelion flower as an active ingredient, it has excellent antioxidant effect and is effective in skin whitening and skin wrinkle relief.
Description
본 발명은 흰민들레 꽃 추출물을 유효성분으로 함유하는 화장료 조성물 및 건강기능식품에 관한 것이다.The present invention relates to a cosmetic composition and health functional food containing a white dandelion flower extract as an active ingredient.
최근에는 환경친화적이고 자연지향적인 소비추세에 따라 기능성 화장품에 들어가는 유효성분이 식물 또는 동물 유래의 천연물 및 화학물질이 그 유용성을 기반으로 하여 여러 가지 형태로 기능성 화장품 내에 배합이 되어서 사용이 되고 있다.In recent years, according to the eco-friendly and nature-oriented consumption trend, active ingredients in functional cosmetics are formulated in various forms in functional cosmetics based on their usefulness based on natural products and chemical substances derived from plants or animals.
특히, 다양한 천연소재인 식물성 원료 및 해양원료를 이용한 기능성 화장품의 개발이 이루어져 천연 기능성 화장품 및 한방 기능성 화장품이 떠오르고 있다.In particular, the development of functional cosmetics using various natural materials, such as vegetable and marine raw materials, has led to the rise of natural functional cosmetics and oriental medicinal functional cosmetics.
기능성 화장품이란, 화장품법에 의한 화장품으로 인체를 청결, 미화하여 피부 및 모발의 건강을 유지 및 증진을 시키고, 매력을 더하여 용모를 밝게 변화시키기 위하여 인체에 뿌리기, 문지르기, 바르기 등의 유사 방법으로 사용되는 물품으로 인체에 대한 작용이 경미한 것을 말한다. Functional cosmetics are cosmetics according to the Cosmetics Act, which clean and beautify the human body to maintain and promote the health of skin and hair, and to brighten the appearance by adding attractiveness. It refers to a product that has a slight effect on the human body.
이러한 기능성 화장품의 이상적인 조건으로는 인체에 해가 없어야 하고, 주름개선의 피부에 멜라닌 색소가 침착하는 것을 방지하여 주근깨 및 기미 등의 생성을 억제하여 피부 미백에 도움을 주는 등의 효과가 있어야 하고, 인체에 대한 작용이 경미 하여야 한다는 점이다.The ideal condition for such functional cosmetics is that there should be no harm to the human body, prevent the deposition of melanin pigment on the wrinkle-improving skin, suppress the formation of freckles and blemishes, etc. The point is that the action on the human body should be mild.
기능성 화장품에 포함되는 화학적 물질의 부작용 때문에 최근 들어 소비자들의 기능성 화장품 내의 화학적 물질이나 첨가물에 대한 사용거부감이 증가하고, 이에 따라 부작용이 적고 기능성의 효과를 볼 수 있는 천연물을 이용한 기능성 화장품에 대한 관심이 급증하고 있다.Due to the side effects of chemical substances included in functional cosmetics, consumers' reluctance to use chemical substances or additives in functional cosmetics has recently increased, and accordingly, interest in functional cosmetics using natural products with few side effects and functional effects has increased. is increasing rapidly.
한편, 우리나라의 양지에서 자생하는 흰민들레는 고유의 재래종으로서, 뼈와 근육 강화, 독소 제거, 해열 작용이 있다고 알려져 있는 식물이다. 흰민들레의 잎과 줄기에 함유하고 있는 실리마린 성분이 효소의 작용을 돕고 세포막을 튼튼하게 하여 간세포 재생을 촉진시켜 간 기능의 개선재로도 많이 이용되고 있다.On the other hand, white dandelion, which grows wild in the sun in Korea, is a native species and is known to strengthen bones and muscles, remove toxins, and reduce fever. The silymarin component contained in the leaves and stems of white dandelion helps the action of enzymes and strengthens the cell membrane to promote hepatocyte regeneration and is widely used as a material for improving liver function.
흰민들레 뿌리의 경우에는 caffeic acid, chicoric acid, chlorogenic acid등의 항산화 활성이 우수한 폴리페놀 화합물들을 다량 함유하고 있어 항암, 항균 및 항산화 활성에 대한 약리작용 연구가 진행되고 있다.In the case of white dandelion root, it contains a large amount of polyphenol compounds with excellent antioxidant activity such as caffeic acid, chicoric acid, and chlorogenic acid.
따라서, 천연물질인 흰민들레를 이용하여 항산화 효과가 우수하고, 피부 미백 및 피부 주름에 효과적인 조성물이 요구되고 있다.Therefore, there is a need for a composition using white dandelion, which is a natural material, which has excellent antioxidant effect and is effective for skin whitening and skin wrinkles.
본 발명의 목적은 흰민들레 꽃 추출물을 유효성분으로 함유하는 피부미백 및 주름 개선용 화장료 조성물을 제공하는데 있다.It is an object of the present invention to provide a cosmetic composition for skin whitening and wrinkle improvement containing a white dandelion flower extract as an active ingredient.
또한, 본 발명의 다른 목적은 흰민들레 꽃 추출물을 유효성분으로 함유하는 피부미백 및 주름 완화용 건강기능식품을 제공하는데 있다.In addition, another object of the present invention is to provide a health functional food for skin whitening and wrinkle relief containing a white dandelion flower extract as an active ingredient.
상기한 목적을 달성하기 위한 본 발명의 피부미백 및 주름 개선용 화장료 조성물은 흰민들레 꽃 추출물을 유효성분으로 함유할 수 있다.The cosmetic composition for skin whitening and wrinkle improvement of the present invention for achieving the above object may contain a white dandelion flower extract as an active ingredient.
상기 흰민들레 꽃 추출물은 물, 탄소수 1 내지 4의 저급알코올 또는 이들의 혼합용매로 추출된 것일 수 있으며, 바람직하게는 열수 추출물일 수 있다.The white dandelion flower extract may be extracted with water, a lower alcohol having 1 to 4 carbon atoms, or a mixed solvent thereof, preferably a hot water extract.
다른 예로, 상기 흰민들레 꽃 추출물은 흰민들레 꽃 열수 추출물을 균주로 발효시킨 발효물일 수 있다.As another example, the white dandelion flower extract may be a fermented product obtained by fermenting the white dandelion flower hot water extract as a strain.
상기 균주는 락토바실러스 플란타룸(Lactobacillus plantarum), 락토바실러스 사케이(Lactobacillus sakei), 류코노스톡 메센테로이데스(Leuconostoc mesenteroides) 및 락토바실러스 부크네리(Lactobacillus buchneri)로 이루어진 군에서 선택된 1종 이상을 들 수 있다.The strain is at least one selected from the group consisting of Lactobacillus plantarum, Lactobacillus sakei, Leuconostoc mesenteroides and Lactobacillus buchneri. can be heard
또한, 상기한 다른 목적을 달성하기 위한 본 발명의 피부미백 및 주름 완화용 건강기능식품은 흰민들레 꽃 추출물을 유효성분으로 함유할 수 있다.In addition, the health functional food for skin whitening and wrinkle relief of the present invention for achieving the above other object may contain a white dandelion flower extract as an active ingredient.
본 발명의 흰민들레 꽃 추출물을 유효성분으로 함유하는 화장료 조성물은 독성이 없으며, 항산화 효과가 우수하고, 피부 미백 및 피부 주름 완화에 효과적이다.The cosmetic composition containing the white dandelion flower extract of the present invention as an active ingredient is non-toxic, has excellent antioxidant effect, and is effective for skin whitening and skin wrinkle relief.
본 발명은 흰민들레 꽃 추출물을 유효성분으로 함유하는 화장료 조성물 및 건강기능식품에 관한 것이다.The present invention relates to a cosmetic composition and health functional food containing a white dandelion flower extract as an active ingredient.
이하, 본 발명을 상세하게 설명한다. Hereinafter, the present invention will be described in detail.
본 발명의 화장료 조성물은 흰민들레 꽃 추출물을 유효성분으로 함유한다.The cosmetic composition of the present invention contains a white dandelion flower extract as an active ingredient.
상기 흰민들레(Taraxacum coreanum)는 원줄기가 없고 굵은 뿌리에서 잎이 무더기로 나와서 비스듬히 퍼진것으로서, 잎은 거꾸로 선 바소 모양이고 밑이 좁아지며 양쪽가장자리는 무잎처럼 갈라진다. 갈래조각은 5~6쌍이며 가장자리에 톱니가 있다. 흰민들레의 어린잎은 생채로 먹거나 살짝 데쳐 나물로 무쳐 먹으며, 뿌리는 튀겨 먹고, 꽃은 그늘에 말려 차로 마신다.The white dandelion ( Taraxacum coreanum ) does not have a main stem, and leaves come out in a pile from a thick root and spread obliquely. Forked fragments are 5-6 pairs, and the edges have serrations. The young leaves of white dandelion are eaten raw or lightly blanched and seasoned with herbs, the roots are fried, and the flowers are dried in the shade and drunk as tea.
본 발명에서는 흰민들레의 꽃을 이용한다. 흰민들레의 꽃 대신 잎, 뿌리 등을 사용하는 경우에는 원하는 효과를 얻을 수 없다.In the present invention, white dandelion flowers are used. If you use leaves, roots, etc. instead of flowers of white dandelion, the desired effect cannot be obtained.
상기 흰민들레 꽃 추출물은 용매로 추출된 용매 추출물 또는 발효된 발효물일 수 있다.The white dandelion flower extract may be a solvent extract extracted with a solvent or a fermented product.
일예로, 흰민들레 꽃 용매 추출물은 추출용매 하에서 초음파처리를 통해 추출되는 것으로서, 구체적으로 흰민들레 꽃과 추출용매가 1 : 5 내지 25, 바람직하게는 1 : 10 내지 20의 중량비로 혼합되어 20 내지 50 kHz, 바람직하게는 30 내지 40 kHz의 진동수 및 50 내지 700 W, 바람직하게는 150 내지 400 W 파워의 초음파기로 50 내지 90 ℃, 바람직하게는 70 내지 80 ℃하에서 5 내지 60분, 바람직하게는 15 내지 30분 동안 처리된다. For example, the white dandelion flower solvent extract is extracted through sonication under an extraction solvent, and specifically, the white dandelion flower and the extraction solvent are mixed in a weight ratio of 1: 5 to 25, preferably 1: 10 to 20, and 20 to 50 kHz, preferably 30 to 40 kHz, and 50 to 700 W, preferably 150 to 400 W power ultrasonicator at 50 to 90 ° C, preferably 70 to 80 ° C for 5 to 60 minutes, preferably Treated for 15 to 30 minutes.
흰민들레 꽃을 추출 시 초음파 추출이 아니라 용매 추출인 경우에는 유효성분이 소량 추출될 뿐만 아니라 항산화, 피부미백 및 피부재생 효과가 낮을 수 있다.When extracting white dandelion flowers, in the case of solvent extraction rather than ultrasonic extraction, not only a small amount of active ingredients are extracted, but also antioxidant, skin whitening and skin regeneration effects may be low.
상기 흰민들레 꽃과 추출용매의 중량비가 상기 범위를 벗어나는 경우에는 추출물에 흰민들레 꽃의 유효성분이 적은 양으로 추출될 수 있다. When the weight ratio of the white dandelion flower to the extraction solvent is out of the above range, the active ingredient of the white dandelion flower may be extracted in a small amount in the extract.
또한, 초음파기의 진동수 및 파워가 상기 하한치 미만인 경우에는 흰민들레 꽃의 유효성분이 적은 양으로 추출될 수 있으며, 상기 상한치 초과인 경우에는 유효성분 외에 다른 물질도 다량으로 추출되어 효과가 저하될 수 있다. In addition, when the frequency and power of the ultrasonicator are less than the lower limit, the active ingredient of the white dandelion flower may be extracted in a small amount, and if it exceeds the upper limit, other substances in addition to the active ingredient are also extracted in a large amount, thereby reducing the effect.
또한, 추출온도 및 추출시간이 상기 하한치 미만인 경우에는 흰민들레 꽃의 유효성분이 적은 양으로 추출될 수 있으며, 상기 상한치 초과인 경우에는 폴리페놀, 플라보노이드 및 펩타이드의 열에 의한 변형으로 인해 기능성이 감소할 수 있다.In addition, when the extraction temperature and extraction time are less than the lower limit, the active ingredient of the white dandelion flower can be extracted in a small amount. have.
상기 추출물을 추출하는 추출용매는 물, 탄소수 1 내지 4의 저급알코올, 에틸렌글리콜, 에틸에테르 또는 이들의 혼합용매이다. 상기 저급알코올로는 20 내지 99 부피%의 메탄올, 에탄올, 부탄올 또는 프로판올 수용액을 들 수 있으며, 바람직하게는 우수한 항산화, 피부미백 및 피부주름 완화를 위하여 물을 들 수 있다.The extraction solvent for extracting the extract is water, a lower alcohol having 1 to 4 carbon atoms, ethylene glycol, ethyl ether, or a mixed solvent thereof. The lower alcohol may include 20 to 99% by volume of methanol, ethanol, butanol or propanol aqueous solution, and preferably water for excellent antioxidant, skin whitening and skin wrinkle relief.
다른 예로, 흰민들레 꽃 발효물은 상기 흰민들레 꽃 초음파 용매 추출물, 바람직하게는 흰민들레 꽃 초음파 열수 추출물에 균주를 접종시킨 후 25 내지 50 ℃에서 100 내지 300 rpm으로 10 내지 30일 동안 발효시킨 것이다. As another example, the white dandelion flower fermented product is the white dandelion flower ultrasonic solvent extract, preferably, after inoculating the strain in the white dandelion flower ultrasonic hot water extract, it is fermented for 10 to 30 days at 25 to 50 ° C. at 100 to 300 rpm. .
상기 균주로는 락토바실러스 플란타룸(Lactobacillus plantarum), 락토바실러스 사케이(Lactobacillus sakei), 류코노스톡 메센테로이데스(Leuconostoc mesenteroides) 및 락토바실러스 부크네리(Lactobacillus buchneri)로 이루어진 군에서 선택된 1종 이상을 들 수 있으며, 베타-글루코시데아제를 생산한다고 알려진 상기 균주 이외에 다른 균주를 사용하는 경우에는 항산화, 피부미백 및 피부주름 완화 효과가 없거나 낮을 수 있다.The strain is at least one selected from the group consisting of Lactobacillus plantarum, Lactobacillus sakei, Leuconostoc mesenteroides and Lactobacillus buchneri. For example, when using a strain other than the strain known to produce beta-glucosidase, the antioxidant, skin whitening and skin wrinkle alleviation effects may be low or absent.
상기 발효 시 온도, 혼합 속도 및 시간이 상기 하한치 미만인 경우에는 흰민들레 꽃의 유효성분이 적은 양으로 추출될 수 있으며, 상기 상한치 초과인 경우에는 생리활성물질의 분해로 인해 원하는 효과가 전혀 발휘되지 못할 수 있다. When the temperature, mixing speed, and time during fermentation are less than the lower limit, the active ingredient of white dandelion flower may be extracted in a small amount, and if it exceeds the upper limit, the desired effect may not be exhibited at all due to the decomposition of physiologically active substances. have.
본 발명의 흰민들레 꽃 추출물은 화장료 조성물 외에 건강기능식품에도 사용될 수 있다.The white dandelion flower extract of the present invention may be used in health functional foods in addition to cosmetic compositions.
본 명세서에서 흰민들레 꽃을 언급하면서 사용되는 용어 '추출물'은 추출용매를 처리하여 얻은 조추출물뿐만 아니라 흰민들레 꽃 추출물의 가공물도 포함한다. 예를 들어, 흰민들레 꽃 추출물은 감압 증류 및 동결 건조 또는 분무 건조 등과 같은 추가적인 과정에 의해 분말 상태로 제조될 수 있다.The term 'extract' used while referring to the white dandelion flower in this specification includes not only the crude extract obtained by treating the extraction solvent but also the processed product of the white dandelion flower extract. For example, the white dandelion flower extract may be prepared in a powder state by an additional process such as distillation under reduced pressure and freeze drying or spray drying.
한편, 본 명세서에서 용어 '유효성분으로 함유하는'이란 흰민들레 꽃 추출물의 효능 또는 활성을 달성하는 데 충분한 양을 포함하는 것을 의미한다. 일예로, 상기 흰민들레 꽃 추출물은 10 내지 1500 ㎍/㎖, 바람직하게는 100 내지 1000 ㎍/㎖의 농도로 사용된다. 흰민들레 꽃 추출물은 천연물로서 과량 사용하여도 인체에 부작용이 없으므로 본 발명의 조성물 내에 포함되는 흰민들레 꽃 추출물의 양적 상한은 당업자가 적절한 범위 내에서 선택하여 실시할 수 있다.Meanwhile, in the present specification, the term 'contained as an active ingredient' means including an amount sufficient to achieve the efficacy or activity of the white dandelion flower extract. For example, the white dandelion flower extract is used at a concentration of 10 to 1500 μg/ml, preferably 100 to 1000 μg/ml. Since the white dandelion flower extract is a natural product and there is no side effect on the human body even when used in excess, the quantitative upper limit of the white dandelion flower extract contained in the composition of the present invention can be selected and implemented by those skilled in the art within an appropriate range.
본 발명의 화장료 조성물에는 상기의 화장료 조성물과 더불어 필요에 따라 통상 화장료에 배합되는 다른 성분을 배합할 수 있으며, 이러한 배합 성분으로서는 유지 성분, 보습제, 에몰리엔트제, 계면 활성제, 유기 및 무기 안료, 유기 분체, 자외선 흡수제, 방부제, 살균제, 산화 방지제, pH 조정제, 알콜, 색소, 향료, 혈행 촉진제, 냉감제, 제한제, 정제수, 수용성 비타민, 지용성 비타민, 고분자 펩티드, 고분자 다당, 스핑고 지질 및 해초 엑기스 등을 들 수 있다.In the cosmetic composition of the present invention, in addition to the above cosmetic composition, other ingredients commonly formulated in cosmetics may be blended as needed. Examples of such blending ingredients include oil and fat ingredients, humectants, emollients, surfactants, organic and inorganic pigments, Organic powder, UV absorber, preservative, disinfectant, antioxidant, pH adjuster, alcohol, colorant, fragrance, blood circulation promoter, cooling agent, limiting agent, purified water, water-soluble vitamin, fat-soluble vitamin, polymer peptide, polymer polysaccharide, sphingolipid and seaweed an extract, etc. are mentioned.
본 발명의 화장료 조성물은 당업계에서 통상 사용되는 유화 제형 및 가용화 제형의 형태로 제조될 수 있다.The cosmetic composition of the present invention may be prepared in the form of emulsified formulations and solubilized formulations commonly used in the art.
또한, 본 발명의 상기 화장료 조성물에 포함되는 성분은 유효성분으로서 상기 성분 이외에 화장료 조성물에 통상적으로 이용되는 성분들을 포함할 수 있으며, 예를 들면, 안정화제, 안료 및 천연향료와 같은 통상적인 보조제 및 담체를 더 포함할 수 있다.In addition, the components included in the cosmetic composition of the present invention may include components commonly used in cosmetic compositions in addition to the above components as active ingredients, for example, conventional adjuvants such as stabilizers, pigments and natural fragrances; It may further include a carrier.
본 발명의 조성물을 첨가할 수 있는 제품으로는, 예를 들어, 미스트, 스킨로션, 스킨소프너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스쳐 로션, 영양로션, 맛사지크림, 영양크림, 자외선 차단크림, 모이스처크림, 핸드크림, 파운데이션, 에센스, 영양에센스, 마스크팩, 프레스파우더, 루스파우더, 아이섀도우 등과 같은 화장품류와 비누, 클렌징폼, 클렌징로션, 클렌징크림, 바디로션 및 바디클린저 등이 있다.Products to which the composition of the present invention can be added include, for example, mist, skin lotion, skin softener, skin toner, astringent, lotion, milk lotion, moisture lotion, nourishing lotion, massage cream, nourishing cream, sunscreen cream , moisture cream, hand cream, foundation, essence, nourishing essence, mask pack, press powder, loose powder, eye shadow, etc., and soap, cleansing foam, cleansing lotion, cleansing cream, body lotion and body cleanser.
본 발명의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물섬유, 식물섬유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the present invention is a paste, cream or gel, animal fiber, vegetable fiber, wax, paraffin, starch, tracanth, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide may be used as a carrier component. can
본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판, 부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component. In particular, in the case of a spray, additional chlorofluorohydrocarbon, propane , butane or propellants such as dimethyl ether.
본 발명의 제형이 용액 또는 유탁액의 경우에는 담체 성분으로서 용매, 용매화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation of the present invention is a solution or emulsion, a solvent, solvating agent or emulsifying agent is used as a carrier component, for example, water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1 ,3-butylglycol oil, glycerol fatty esters, fatty acid esters of polyethylene glycol or sorbitan.
본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.When the formulation of the present invention is a suspension, as a carrier component, water, a liquid diluent such as ethanol or propylene glycol, a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol esters and polyoxyethylene sorbitan esters, microcrystalline Cellulose, aluminum metahydroxide, bentonite, agar or tracanth may be used.
또한, 본 발명은 흰민들레 꽃 추출물을 유효성분으로 함유하는 건강기능식품 조성물을 제공한다.In addition, the present invention provides a health functional food composition comprising a white dandelion flower extract as an active ingredient.
건강기능식품이란, 흰민들레 꽃 추출물을 음료, 차류, 향신료, 껌, 과자류 등의 식품소재에 첨가하거나, 캡슐화, 분말화, 현탁액 등으로 제조한 식품으로, 이를 섭취할 경우 건강상 특정한 효과를 가져오는 것을 의미하나, 일반 약품과는 달리 식품을 원료로 하여 약품의 장기 복용시 발생할 수 있는 부작용 등이 없는 장점이 있다. 이와 같이 하여 얻어지는 본 발명의 건강기능식품은, 일상적으로 섭취하는 것이 가능하기 때문에 매우 유용하다. 이와 같은 건강기능식품에 있어서의 흰민들레 꽃 추출물의 첨가량은, 대상인 건강기능식품의 종류에 따라 달라 일률적으로 규정할 수 없지만, 식품 본래의 맛을 손상시키지 않는 범위에서 첨가하면 되며, 대상 식품에 대하여 통상 0.01 내지 50 중량%, 바람직하기로는 0.1 내지 20 중량%의 범위이다. 또한, 환제, 과립제, 정제 또는 캡슐제 형태의 건강기능식품의 경우에는 통상 0.1 내지 100 중량% 바람직하기로는 0.5 내지 80 중량%의 범위에서 첨가하면 된다. 한 구체예에서, 본 발명의 건강기능식품은 환제, 정제, 캡슐제 또는 음료의 형태일 수 있다.Health functional food is a food prepared by adding white dandelion flower extract to food materials such as beverages, tea, spices, gum, and confectionery, or by encapsulating, powdering, or suspension, etc. However, unlike general drugs, it has the advantage of not having side effects that may occur when taking the drug for a long period of time by using food as a raw material. The health functional food of the present invention obtained in this way is very useful because it can be ingested on a daily basis. The amount of white dandelion flower extract added in such a health functional food cannot be uniformly defined as it varies depending on the type of health functional food, but it can be added within a range that does not impair the original taste of the food. It is usually in the range of 0.01 to 50% by weight, preferably 0.1 to 20% by weight. In addition, in the case of a health functional food in the form of pills, granules, tablets or capsules, it is usually added in an amount of 0.1 to 100% by weight, preferably 0.5 to 80% by weight. In one embodiment, the health functional food of the present invention may be in the form of a pill, tablet, capsule or beverage.
이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예를 제시하나, 하기 실시예는 본 발명을 예시하는 것일 뿐 본 발명의 범주 및 기술사상 범위 내에서 다양한 변경 및 수정이 가능함은 당업자에게 있어서 명백한 것이며, 이러한 변형 및 수정이 첨부된 특허청구범위에 속하는 것도 당연한 것이다.Hereinafter, preferred examples are presented to help the understanding of the present invention, but the following examples are merely illustrative of the present invention, and it will be apparent to those skilled in the art that various changes and modifications are possible within the scope and spirit of the present invention, It goes without saying that such variations and modifications fall within the scope of the appended claims.
실시예 1. 초음파 열수 추출물Example 1. Ultrasonic hot water extract
흰민들레 꽃과 물을 1 : 20의 중량비로 혼합하여 초음파기(JAC Ultrasinic, Hwaseng, Korea)에 투입 후 80 ℃ 하에서 초음파(40 kHz, 200 W)를 이용하여 30분 동안 추출한 다음 추출물을 1000 rpm에서 5분 동안 원심분리하여 상등액을 회수함으로써 흰민들레 꽃 초음파 열수 추출물을 수득하였다.White dandelion flower and water were mixed in a weight ratio of 1:20, put in an ultrasonicator (JAC Ultrasinic, Hwaseng, Korea), and extracted for 30 minutes using ultrasonic waves (40 kHz, 200 W) at 80 ° C. Then, the extract was extracted at 1000 rpm. The supernatant was recovered by centrifugation for 5 minutes to obtain an ultrasonic hot water extract of white dandelion flower.
실시예 2. 발효물Example 2. Fermented product
배양액culture medium
류코노스톡 메센테로이데스를 MRS broth에 1% 접종하여 37 ℃에서 24시간 배양하여 배양액으로 사용하였다.Leukonostok mecenteroides was inoculated with 1% MRS broth and cultured for 24 hours at 37° C. to be used as a culture medium.
발효물fermented product
상기 실시예 1에서 제조된 초음파 열수 추출물과 류코노스톡 메센테로이데스를 1 : 2의 중량비로 혼합하여 pH를 6.95~7.05로 조절한 후 상기 혼합액 100 중량부에 당 1 중량부를 추가하여 37 ℃에서 48시간 발효한 후 Homogenizer(HG-15A, DAIHAN, Korea)를 이용해 파쇄하고 pH 4.78ㅁ0.05로 조절하여 45 ℃에서 48시간 또 발효한 다음 원심분리하여 상등액을 회수함으로써 흰민들레 꽃 발효물을 수득하였다.The ultrasonic hot water extract prepared in Example 1 and Leukonostok mecenteroides were mixed in a weight ratio of 1: 2 to adjust the pH to 6.95 to 7.05, and then 1 part by weight per 100 parts by weight of the mixture was added and at 37 ° C. After fermenting for 48 hours, crushed using a Homogenizer (HG-15A, DAIHAN, Korea), adjusted to pH 4.78w0.05, fermented at 45° C. for 48 hours, and then centrifuged to recover the supernatant to obtain a fermented white dandelion flower. .
비교예 1. 초음파 에탄올 추출물Comparative Example 1. Ultrasonic Ethanol Extract
상기 실시예 1과 동일하게 실시하되, 물 대신 80 부피% 에탄올 수용액을 이용하여 흰민들레 에탄올 추출물을 수득하였다.It was carried out in the same manner as in Example 1, except that an 80% by volume aqueous ethanol solution was used instead of water to obtain an ethanol extract of white dandelion.
비교예 2. 초음파 메탄올 추출물Comparative Example 2. Ultrasonic Methanol Extract
상기 실시예 1과 동일하게 실시하되, 물 대신 80 부피% 메탄올 수용액을 이용하여 흰민들레 메탄올 추출물을 수득하였다.It was carried out in the same manner as in Example 1, except that an 80% by volume aqueous methanol solution was used instead of water to obtain a methanol extract of white dandelion.
비교예 3. 에탄올 발효물Comparative Example 3. Ethanol Fermented Product
상기 비교예 1에서 제조된 에탄올 추출물에 실시예 2와 같이 류코노스톡 메센테로이데스를 이용하여 발효시킴으로써 흰민들레 꽃 에탄올 발효물을 수득하였다.By fermenting the ethanol extract prepared in Comparative Example 1 using Leukonostok mecenteroides as in Example 2, an ethanol fermented product of white dandelion flower was obtained.
<시험예><Test Example>
시험예 1. 총 폴리페놀 함량, 총 플라보노이드 함량 및 DPPH 소거능 측정Test Example 1. Measurement of total polyphenol content, total flavonoid content and DPPH scavenging ability
1-1. 총 폴리페놀 함량(mg GAE/g DW): Folin-Denis 방법을 변형하여 측정하였으며, folin-ciocalteu's 페놀 용액(Folin & Ciocalteu's phenol; Sigma-Aldrich, USA)을 시료에 첨가하여 폴리페놀 화합물에 의해 환원되어 발생하는 몰리브덴 청색발색 반응을 원리로 하였다. 시료 0.14 ㎖에 0.2 N F.C용액을 첨가하여 10분 동안 방치 후 7.5% Na2CO3 0.56 ㎖을 첨가하여 1시간 동안 반응시켜 흡광도 값을 756 nm에서 측정하였다. 표준물질로 gallic acid(Sigma-Aldrich, USA)를 사용하였고, 단위는 작성한 gallic acid 검량선과 비교하여 mg gallic acid equivalent(GAE)/g dry weight(DW) 로 표시하였다.1-1. Total polyphenol content (mg GAE/g DW): Measured by modifying the Folin-Denis method, folin-ciocalteu's phenol solution (Folin &Ciocalteu'sphenol; Sigma-Aldrich, USA) was added to the sample and reduced by a polyphenol compound The molybdenum blue color reaction generated by the process was based on the principle. After adding 0.2 N FC solution to 0.14 ml of the sample and leaving it for 10 minutes, 0.56 ml of 7.5% Na 2 CO 3 was added and reacted for 1 hour, and the absorbance value was measured at 756 nm. Gallic acid (Sigma-Aldrich, USA) was used as a standard material, and the unit was expressed as mg gallic acid equivalent (GAE)/g dry weight (DW) compared with the prepared gallic acid calibration curve.
1-2. 총 플라보노이드 함량 (total flavonoid content, TFC) : TFC 함량은 Zhishen 등의 방법을 변형하여 사용하였다[21]. 플라보노이드에 알칼리를 작용시키면 황색으로 발색되는 원리에 근거하여 흡광도를 측정해 TFC 농도를 측정하였다. 각 시료 0.5 mL에 증류수 2.5 mL와 99.5% (v/v) 에탄올 1.5 mL 가한 후 1 M potassium acetate 0.1 mL와 10% aluminum chloride 0.1 mL를 가하여 교반한 후 실온에서 30 min 방치하였다. 415 nm 에서 흡광도를 측정하였으며 quercetin (Sigma-Aldrich, Minneapolis, USA)을 25, 50, 100, 200 ㅅg/mL로 희석하여 검량선을 구하여 플라보노이드 함량을 mg quercetin equivalent (QE)/g dry matter (DM)로 나타내었다. 1-2. Total flavonoid content (TFC): The TFC content was used by modifying the method of Zhishen et al. [21]. TFC concentration was measured by measuring absorbance based on the principle that yellow color develops when alkali is applied to flavonoids. To 0.5 mL of each sample, 2.5 mL of distilled water and 1.5 mL of 99.5% (v/v) ethanol were added, then 0.1 mL of 1 M potassium acetate and 0.1 mL of 10% aluminum chloride were added, stirred, and left at room temperature for 30 min. Absorbance was measured at 415 nm, and a calibration curve was obtained by diluting quercetin (Sigma-Aldrich, Minneapolis, USA) to 25, 50, 100, 200 g/mL to determine the flavonoid content in mg quercetin equivalent (QE)/g dry matter (DM ) is shown.
1-3. DPPH 소거능(%): 전자공여능은 Blois의 방법을 변형하여 측정하였으며 항산화 활성이 있는 물질과 반응하여 짙은 보라색에서 노란색으로 색이 엷어지는 원리를 이용한 DPPH(2,2-Diphenyl-1-picrylhydrazyl, Sigma-Aldrich) free radical 소거활성을 통해 시료의 환원력을 측정하였다. 시료 0.25 ㎖에 DPPH 용액 1.25 ㎖을 가하여 암실에서 20분 동안 반응시킨 후 517 nm에서 흡광도를 측정하였으며 시료를 첨가하지 않은 대조군의 흡광도를 기준으로 하기 [수학식 1]에 따라 DPPH 라디칼 소거활성을 백분율로 표시하였다.1-3. DPPH scavenging ability (%): The electron donating ability was measured by modifying the method of Blois, and DPPH (2,2-Diphenyl-1-picrylhydrazyl, Sigma -Aldrich) The reducing power of the sample was measured through free radical scavenging activity. After adding 1.25 ml of DPPH solution to 0.25 ml of sample and reacting for 20 minutes in the dark, absorbance was measured at 517 nm. Based on the absorbance of the control group not adding the sample, the percentage of DPPH radical scavenging activity according to the following [Equation 1] indicated as
[수학식 1][Equation 1]
DPPH radical scavenging activity (%)={1-(Abs(test)-Abs(color))/Abs(control)}X100DPPH radical scavenging activity (%)={1-(Abs(test)-Abs(color))/Abs(control)}X100
(mg GAE/g DW)total polyphenols
(mg GAE/g DW)
(mg QE/g DM)total flavonoids
(mg QE/g DM)
위 표 1에 나타낸 바와 같이, 본 발명의 실시예 1 및 2에 따라 제조된 흰민들레 꽃 초음파 열수 추출물 및 발효물은 비교예 1 내지 3에 비하여 총 폴리페놀 함량 및 총 플라보노이드 함량이 높으며 DPPH 소거능이 우수한 것을 확인하였다.As shown in Table 1 above, the ultrasonic hot water extract and fermented product of white dandelion flower prepared according to Examples 1 and 2 of the present invention had higher total polyphenol content and total flavonoid content than Comparative Examples 1 to 3, and had higher DPPH scavenging ability. It was confirmed that it was excellent.
특히, 실시예 2의 발효물이 실시예 1의 초음파 열수 추출물에 비하여 총 폴리페놀 함량 및 총 플라보노이드 함량이 높으며 DPPH 소거능이 우수한 것을 확인하였으며, 발효물이 우수한 결과를 보인 실시예 1 및 2와 반대로 비교예 3의 에탄올 발효물은 비교예 1의 초음파 에탄올 추출물에 비하여 총 폴리페놀 함량, 총 플라보노이드 함량 및 DPPH 소거능이 낮은 것을 확인하였다 .In particular, it was confirmed that the fermented product of Example 2 had higher total polyphenol content and total flavonoid content and excellent DPPH scavenging ability compared to the ultrasonic hot water extract of Example 1. Contrary to Examples 1 and 2, where the fermented product showed excellent results It was confirmed that the ethanol fermentation product of Comparative Example 3 had lower total polyphenol content, total flavonoid content and DPPH scavenging ability than the ultrasonic ethanol extract of Comparative Example 1.
폴리페놀 및 플라보노이드는 항산화 효과가 우수하므로 실시예 1 및 2에 따라 제조된 흰민들레 꽃 초음파 추출물 및 발효물이 비교예 1 내지 3에 비하여 항산화 효과가 우수하다는 것을 알 수 있다.Since polyphenols and flavonoids have excellent antioxidant effects, it can be seen that the ultrasonic extracts and fermented products of white dandelion flowers prepared according to Examples 1 and 2 have excellent antioxidant effects compared to Comparative Examples 1 to 3.
또한, 항산화 활성의 지표인 DPPH radical 소거능을 측정한 결과, 총 폴리페놀 및 총 플라보노이드 함량과 비례 관계를 확인하였다.In addition, as a result of measuring the DPPH radical scavenging ability, which is an index of antioxidant activity, a proportional relationship with the total polyphenol and total flavonoid content was confirmed.
시험예 2. 티로시나아제(Tyrosinase) 및 콜라게나아제(Collagenase) 활성 저해Test Example 2. Tyrosinase (Tyrosinase) and collagenase (Collagenase) activity inhibition
2-1. 티로시나아제 활성 억제 측정: 티로시나아제의 저해 활성은 Flurkey의 방법을 변형하여 실험하였다. sodium phosphate monobasic anhydrous 0.8039 g, sodium phosphate dibasic anhydrous 0.9511 g을 각각 증류수 100 mL에 녹여 PH를 6.8로 조정하여 buffer를 제조하였다. 제조된 buffer로 기질10mM 3,4-dihydroxy phenylanin(I-dopa) (20 mg/mL)와 효소 1250unit tyrosinase를 제조하였으며 1250 unit tyrosinase는 증류수에 10배 희석하여 사용하였다. 양성 대조군으로는 kojic acid(2 mg/mL)를 제조하였다. 2 mL 마이크로튜브에 buffer 0.4 g, 기질 0.2 g, 시료 0.2g, 효소 0.2 g을 순서대로 첨가하여 교반한 뒤 25℃에서 30 분간 반응시켰다. 반응 후 475 nm에서 흡광도를 측정하였다. 2-1. Measurement of inhibition of tyrosinase activity: The inhibitory activity of tyrosinase was tested by modifying Flurkey's method. A buffer was prepared by dissolving 0.8039 g of sodium phosphate monobasic anhydrous and 0.9511 g of sodium phosphate dibasic anhydrous in 100 mL of distilled water, respectively, and adjusting the pH to 6.8. As the prepared buffer, the substrate 10 mM 3,4-dihydroxy phenylanin (I-dopa) (20 mg/mL) and the enzyme 1250 unit tyrosinase were prepared, and 1250 unit tyrosinase was diluted 10-fold in distilled water and used. As a positive control, kojic acid (2 mg/mL) was prepared. In a 2 mL microtube, 0.4 g of buffer, 0.2 g of substrate, 0.2 g of sample, and 0.2 g of enzyme were sequentially added and stirred, followed by reaction at 25° C. for 30 minutes. After the reaction, absorbance was measured at 475 nm.
[수학식 2][Equation 2]
티로시나아제 저해율(Inhibitory activity, %) = [1-시료OD/ 대조군OD]*100 Tyrosinase inhibition rate (inhibitory activity, %) = [1-sample OD / control OD] * 100
2-2. 콜라게나아제 저해 효과 측정: 콜라게나아제 저해 효과는 Wㆌsch와 Heidrich의 방법을 변형하여 측정하였다. 0.1 M tris와 4 mM cacl2 혼합액에 1 M Hcl을 첨가하여 buffer의 PH를 7.5로 조정하였다. 제조된 buffer에 기질 4-phenylazobenzyloxycarbonyl-Pro-Leu-Gly-Pro-D-Arg(1.2 mg/mL)와 효소 collagenase(0.4 mg/mL)를 제조하였으며 양성 대조군 L-ascorbic acid를 추출 시료의 고액비에 맞추어 제조하였다. 마이크로튜브에 조건별로 추출한 시료 0.05 g, 음성대조군과 양성대조군에는 시료대신 각각 증류수와 L-ascorbid acid를 첨가한 후 효소 0.075 g, 기질 0.125 g을 순서대로 첨가하여 교반한 뒤 37 ℃에서 30분간 반응시켰다. 반응 후 20% citric acid 0.25 mL를 첨가하여 반응을 정지시킨 다음 ethyl acetate 1.2 mL을 첨가하여 10 분간 RPM 120에 교반하였다. 그 후 원심분리한 뒤 상등액만 분리하여 320 nm에서 흡광도를 측정하였다. 2-2. Measurement of Collagenase Inhibitory Effect: The collagenase inhibitory effect was measured by modifying the method of Wㆌsch and Heidrich. The pH of the buffer was adjusted to 7.5 by adding 1 M Hcl to a mixture of 0.1 M tris and 4 mM cacl2. The substrate 4-phenylazobenzyloxycarbonyl-Pro-Leu-Gly-Pro-D-Arg (1.2 mg/mL) and the enzyme collagenase (0.4 mg/mL) were prepared in the prepared buffer, and the positive control L-ascorbic acid was added to the high-liquid ratio of the extraction sample. was prepared according to Distilled water and L-ascorbid acid were added to the microtube for each condition, respectively, distilled water and L-ascorbid acid were added instead of the sample to 0.05 g, negative control and positive control. Then, 0.075 g of enzyme and 0.125 g of substrate were added in order, stirred, and reacted at 37°C for 30 minutes. did it After the reaction, 0.25 mL of 20% citric acid was added to stop the reaction, and 1.2 mL of ethyl acetate was added, followed by stirring at RPM 120 for 10 minutes. After centrifugation, only the supernatant was separated and absorbance was measured at 320 nm.
[수학식 3][Equation 3]
콜라게나아제 저해율(Inhibitory activity, %) = [1-시료OD/ 대조군OD]*100Collagenase inhibition rate (inhibitory activity, %) = [1-sample OD / control OD] * 100
위 표 2에 나타낸 바와 같이, 본 발명의 실시예 1 및 2에 따라 제조된 흰민들레 꽃 초음파 열수 추출물 및 발효물은 비교예 1 내지 3에 비하여 티로시나아제 저해율 및 콜라게나아제 저해율이 높은 것을 확인하였다.As shown in Table 2 above, it was confirmed that the ultrasonic hot water extract and fermented product of white dandelion flower prepared according to Examples 1 and 2 of the present invention had higher tyrosinase inhibition and collagenase inhibition than Comparative Examples 1-3. did.
특히, 실시예 2의 발효물이 실시예 1의 초음파 열수 추출물에 비하여 티로시나아제 저해율 및 콜라게나아제 저해율이 높은 것을 확인하였으며, 발효물이 우수한 결과를 보인 실시예 1 및 2와 반대로 비교예 3의 에탄올 발효물은 비교예 1의 초음파 에탄올 추출물에 비하여 티로시나아제 저해율 및 콜라게나아제 저해율 낮은 것을 확인하였다.In particular, it was confirmed that the fermented product of Example 2 had higher tyrosinase inhibition and collagenase inhibition than the ultrasonic hot water extract of Example 1, and Comparative Example 3 as opposed to Examples 1 and 2, where the fermented product showed excellent results. It was confirmed that the ethanol fermented product of Comparative Example 1 had a lower tyrosinase inhibition rate and a lower collagenase inhibition rate than the ultrasonic ethanol extract of Comparative Example 1.
하기에 본 발명의 분말을 함유하는 조성물의 제제예를 설명하나, 본 발명은 이를 한정하고자 함이 아닌 단지 구체적으로 설명하고자 함이다.Hereinafter, formulation examples of the composition containing the powder of the present invention will be described, but the present invention is not intended to limit the present invention, but merely to describe it in detail.
제조예 1. 과립제의 제조Preparation Example 1. Preparation of granules
실시예 2에서 얻은 발효물 분말 1,000 mg1,000 mg of fermented product powder obtained in Example 2
비타민 혼합물 적량appropriate amount of vitamin mixture
비타민 A 아세테이트 70 ㎍70 μg vitamin A acetate
비타민 E 1.0 mgVitamin E 1.0 mg
비타민 B1 0.13 mgVitamin B1 0.13 mg
비타민 B2 0.15 mgVitamin B2 0.15 mg
비타민 B6 0.5 mg0.5 mg of vitamin B6
비타민 B12 0.2 ㎍0.2 μg of vitamin B12
비타민 C 10 mgVitamin C 10 mg
비오틴 10 ㎍Biotin 10 μg
니코틴산아미드 1.7 mgNicotinamide 1.7 mg
엽산 50 ㎍50 μg folic acid
판토텐산 칼슘 0.5 mgCalcium pantothenate 0.5 mg
무기질 혼합물 적량Appropriate amount of inorganic mixture
황산제1철 1.75 mgferrous sulfate 1.75 mg
산화아연 0.82 mgZinc Oxide 0.82 mg
탄산마그네슘 25.3 mgMagnesium carbonate 25.3 mg
제1인산칼륨 15 mgPotassium monophosphate 15 mg
제2인산칼슘 55 mgDibasic calcium phosphate 55 mg
구연산칼륨 90 mgPotassium citrate 90 mg
탄산칼슘 100 mg100 mg calcium carbonate
염화마그네슘 24.8 mgMagnesium chloride 24.8 mg
상기의 비타민 및 미네랄 혼합물의 조성비는 비교적 과립제에 적합한 성분을 바람직한 실시예로 혼합 조성하였지만, 그 배합비를 임의로 변형 실시하여도 무방하며, 통상의 과립제 제조방법에 따라 상기의 성분을 혼합한 다음, 과립을 제조하고, 통상의 방법에 따라 건강기능식품 조성물 제조에 사용할 수 있다.The composition ratio of the vitamin and mineral mixture is relatively suitable for granules in a preferred embodiment, but the mixing ratio may be arbitrarily modified. It can be prepared and used in the preparation of a health functional food composition according to a conventional method.
제조예 2. 기능성 음료의 제조Preparation Example 2. Preparation of functional beverage
실시예 2에서 얻은 발효물 분말 1,000 mg1,000 mg of fermented product powder obtained in Example 2
구연산 1,000 mg1,000 mg citric acid
올리고당 100 g100 g of oligosaccharides
매실농축액 2 g2 g of plum concentrate
타우린 1 g1 g taurine
정제수를 가하여 전체 900 mLAdd purified water to total 900 mL
통상의 건강음료 제조방법에 따라 상기의 성분을 혼합한 다음, 약 1 시간 동안 85 ℃에서 교반 가열한 후, 만들어진 용액을 여과하여 멸균된 2 L 용기에 취득하여 밀봉 멸균한 뒤 냉장 보관한 다음 본 발명의 기능성 음료 조성물 제조에 사용한다. After mixing the above ingredients according to the usual health drink manufacturing method, after stirring and heating at 85 ° C for about 1 hour, the resulting solution is filtered and acquired in a sterilized 2 L container, sealed and sterilized, then refrigerated. It is used to prepare the functional beverage composition of the present invention.
상기 조성비는 비교적 기호음료에 적합한 성분을 바람직한 실시예로 혼합 조성하였지만, 수요계층, 수요국가, 사용용도 등 지역적, 민족적 기호도에 따라서 그 배합비를 임의로 변형 실시하여도 무방하다.Although the composition ratio is prepared by mixing ingredients suitable for relatively favorite beverages in a preferred embodiment, the mixing ratio may be arbitrarily modified according to regional and national preferences such as demand class, demanding country, and use.
본 발명을 적용하기에 적합한 화장료 조성물의 제조예를 제시하기로 한다.A preparation example of a cosmetic composition suitable for applying the present invention will be presented.
제조예 3: 화장수Preparation example 3: lotion
실시예 2의 발효물을 포함하는 화장료 중 화장수의 제조예는 하기 표 3과 같다.Preparation examples of the lotion in the cosmetic including the fermented product of Example 2 are shown in Table 3 below.
제조예 4: 로션Preparation Example 4: Lotion
실시예 1의 탈지미세조류 효소분해물을 포함하는 화장료 중 로션의 제조예는 하기 표 4와 같다.Preparation examples of lotions in the cosmetic containing the degreasing microalgae enzyme decomposition product of Example 1 are shown in Table 4 below.
제조예 5: 영양 크림Preparation Example 5: Nourishing Cream
실시예 2의 발효물을 포함하는 화장료 중 영양 크림의 제조예는 하기 표 5와 같다.A preparation example of a nutritional cream in a cosmetic comprising the fermented product of Example 2 is shown in Table 5 below.
제조예 6: 에센스Preparation 6: Essence
실시예 2의 발효물을 포함하는 화장료 중 에센스의 제조예는 하기 표 6과 같다.Preparation examples of the essence in the cosmetic including the fermented product of Example 2 are shown in Table 6 below.
제조예 7: 마스크 팩용 유액Preparation Example 7: Emulsion for mask pack
실시예 2의 발효물을 포함하는 화장료 중 마스크 팩용 유액의 제조예는 하기 표 7과 같다.Preparation examples of the emulsion for a mask pack among the cosmetics containing the fermented product of Example 2 are shown in Table 7 below.
Claims (8)
상기 흰민들레 꽃 초음파 추출물은 흰민들레 꽃과 물이 1 : 5 내지 25의 중량비로 혼합된 혼합물을 50 내지 90 ℃ 하에서 20 내지 50 kHz의 진동수 및 50 내지 700 W의 파워의 초음파기로 5 내지 60분 동안 처리하여 수득된 것을 특징으로 하는 피부 미백 및 주름 개선용 화장료 조성물.A cosmetic composition for skin whitening and wrinkle improvement comprising an ultrasonic extract of white dandelion flower as an active ingredient,
The ultrasonic extract of white dandelion flower is a mixture of white dandelion flower and water in a weight ratio of 1: 5 to 25 with an ultrasonicator of a frequency of 20 to 50 kHz and a power of 50 to 700 W under 50 to 90 ° C. for 5 to 60 minutes. A cosmetic composition for skin whitening and wrinkle improvement, characterized in that obtained by treatment during
상기 흰민들레 꽃 초음파 추출물은 흰민들레 꽃과 물이 1 : 5 내지 25의 중량비로 혼합된 혼합물을 50 내지 90 ℃ 하에서 20 내지 50 kHz의 진동수 및 50 내지 700 W의 파워의 초음파기로 5 내지 60분 동안 처리하여 수득된 것을 특징으로 하는 피부미백 및 주름 완화용 건강기능식품.As a health functional food for skin whitening and wrinkle relief, comprising an ultrasonic extract of white dandelion flower as an active ingredient,
The ultrasonic extract of white dandelion flower is a mixture of white dandelion flower and water in a weight ratio of 1: 5 to 25 with an ultrasonicator of a frequency of 20 to 50 kHz and a power of 50 to 700 W under 50 to 90 ° C. for 5 to 60 minutes. Health functional food for skin whitening and wrinkle relief, characterized in that obtained by treatment during
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200086596A KR102449136B1 (en) | 2020-07-14 | 2020-07-14 | Compositions containing Taraxacum coreanum extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200086596A KR102449136B1 (en) | 2020-07-14 | 2020-07-14 | Compositions containing Taraxacum coreanum extract |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20220008483A KR20220008483A (en) | 2022-01-21 |
KR102449136B1 true KR102449136B1 (en) | 2022-09-29 |
Family
ID=80050232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200086596A KR102449136B1 (en) | 2020-07-14 | 2020-07-14 | Compositions containing Taraxacum coreanum extract |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102449136B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102671383B1 (en) * | 2023-10-04 | 2024-05-31 | 한국콜마주식회사 | Korean dandelion extract with excellent skin moisturizing and barrier effects and its manufacturing process |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0195200A (en) * | 1987-10-07 | 1989-04-13 | Shirasagi Kagaku Gijutsu Kenkyusho:Kk | Detergent composition |
KR20170055368A (en) | 2015-11-11 | 2017-05-19 | 대한민국(농촌진흥청장) | A composition for alleviating or treating symptoms caused by liver function decreases comprising taraxacum coreanum root extract |
KR20170055366A (en) | 2015-11-11 | 2017-05-19 | 대한민국(농촌진흥청장) | A composition for preventing or treating obesity comprising taraxacum coreanum root extract |
-
2020
- 2020-07-14 KR KR1020200086596A patent/KR102449136B1/en active IP Right Grant
Non-Patent Citations (2)
Title |
---|
흰민들레 열수 추출물 및 분획물의 피부 관련 생리활성, 생약회지, 42(2), 195-200(2011.) 1부.* |
흰민들레 효능 성분, 민들레 차 먹는 법(2019.01.26.) 1부.* |
Also Published As
Publication number | Publication date |
---|---|
KR20220008483A (en) | 2022-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102194315B1 (en) | Antioxidant or skin microbiome balance cosmetic composition comprising centella asiatica fermented extract fermented by inoculating lactobacillus rhamnosus strain | |
KR20210114893A (en) | Cosmetic and OTC drug composition comprising peach fermented extract as an active ingredient | |
KR101821024B1 (en) | COMPOSITION OF SKIN WHITENING CONTAINING EXTRACT OF Gloiopeltis Furcata AND METHOD OF MAKING THE SAME | |
KR20220018309A (en) | Compositions containing Sargassum horneri (Turner) C. Agardh extract | |
KR20180071721A (en) | Composition for antioxidant or improving skin wrinkle comprising fermented Cudrania tricuspidata extract | |
KR102449136B1 (en) | Compositions containing Taraxacum coreanum extract | |
KR102544792B1 (en) | Composition Comprising Complex Extract of seaweeds Fermented by Lactobacillus Brevis with Anti-Wrinkling and Elasticity, Antioxidant, and Skin Hydration Property as Active Ingredient | |
KR102632743B1 (en) | Composition for strengthening skin barrier containing Ganoderma lucidum extract as an active ingredient | |
KR101980142B1 (en) | Method for producing chestnut inner shell extract with increased skin-whitening and anti-wrinkle using enzyme and autoclave treatment | |
KR20200083293A (en) | Cosmetic composition comprising mixture of fermented extract of Cirsium japonicum and Moringa oleifera | |
KR102014312B1 (en) | Skin-whitening functional composition including polyopes affinis extracts | |
KR102370528B1 (en) | Compositions containing Beta vulgaris fermentation extract | |
KR102399204B1 (en) | Compositions containing black garlic extract | |
KR102628844B1 (en) | Cosmetic composition for anti-oxidation, skin whitening and anti-wrinkle containing a mixed fermentation extracts of Wisteria floribunda flowers, Aralia elata flowers, Camellia japonica leafs and Camellia japonica flowers as effective component | |
KR102154139B1 (en) | Composition comprising fermentation of sap of painted maple, cacao nibs extract and granat extract | |
KR20230052573A (en) | Compositions for skin whitening and anti-wrinkle containing fermented spirulina extract | |
KR102252855B1 (en) | Cosmetic composition comprising nano-ized lactobacillus genus dead cells and a method for producing the same | |
KR102154140B1 (en) | Composition comprising tulip leaf extract, amorphophallus paeoniifolius hydrolysis extract and parrot ferment extract | |
KR102331119B1 (en) | Composition for preventing skin anti-aging comprising fermented black rice extract and fermented peanut sprout extract | |
KR102128168B1 (en) | Composition comprising the extract of Lentinula edodes and Acer pictum subsp. mono leaf for antioxidant effect | |
KR102117761B1 (en) | Red sea cucumber-derived low salt peptide powder and process for producing the same | |
KR102612332B1 (en) | Compositions for skin whitening and anti-wrinkle containing fermented moringa extract | |
KR20230054129A (en) | Antioxidant, skin whitening and skin wrinkle improvement composition | |
KR102401490B1 (en) | Compositions containing Angelica gigas extract | |
KR101995384B1 (en) | Composition for skin whitening and anti-oxidation comprising fermented Gynura procumbens as effective component |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |